Certified French language Translation of Supplementary Reasons for Judgment and Judgment rendered on 07-JUN-2013 by The Honourable Mr. Justice Barnes filed on 30-JUL-2013 pursuant to s. 20 of the Official Languages Act. Copy of Translation of Reasons for Supplementary Reasons for Judgment and Judgment entered in J. & O. Book, volume 1201 page(s) 53 - 58

Acknowledgment of Receipt received from all parties with respect to Supplementary Reasons for Judgment and Judgment (Doc. No. 55). placed on file on 07-JUN-2013

Supplementary Reasons for Judgment and Judgment dated 07-JUN-2013 rendered by The Honourable Mr. Justice Barnes Matter considered without personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: "THIS COURT'S JUDGMENT is that Lilly will have its costs of this application under Column III and its reasonable disbursements up to the point of the withdrawl of Teva's Notice of Allegation. This figure shall be reduced by $2,000.00 representing Teva's costs of sucessfully defending Lilly's motion for a prohibition Order. THIS COURTMS FURTHER JUDGMENT is that Lilly is entitled to recover $12,500.00 for its disbursements in connection with the retention of expert witnesses in this proceeding." 3 Filed on 07-JUN-2013 entered in J. & O. Book, volume 1195 page(s) 241 - 245 Interlocutory Decision

Corrected translation of the Reasons for Judgment and Judgment dated 14-January-2013 received on 08-MAY-2013

Corrections to page(s) 2 5 of the Reasons of The Honourable Mr. Justice Barnes that were dated 14-JAN-2013 received on 27-MAR-2013 Corrected pages sent to parties

Certified French language Translation of Reasons for Judgment and Judgment rendered on 14-JAN-2013 by The Honourable Mr. Justice Barnes filed on 18-FEB-2013 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Judgment entered in J. & O. Book, volume 1184 page(s) 148 - 148 and copy placed on file.

Solicitor's certificate of service on behalf of Andy Radhakant confirming service of Doc.52 and Book of Authorities upon all parties by personal service on 04-FEB-2013 filed on 04-FEB-2013

Book of Authorities consisting of 1 volume(s) on behalf of Respondent - Teva Canada Limited received on 04-FEB-2013

Written Submissions on Costs on behalf of Respondent - Teva Canada Limited concerning Order of Barnes, J dated 14-JAN-2013 filed on 04-FEB-2013

Communication to the Court from the Registry dated 07-FEB-2013 re: File sent to Justice Barnes re: Doc. # 50

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of doc. 50 and authorities upon all parties by personal service on 28-JAN-2013 filed on 28-JAN-2013

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 28-JAN-2013

Written Written submissions on costs on behalf of Applicant concerning Paragraph 15 of Reasons for Judgment dated January 14, 2013 filed on 28-JAN-2013

Acknowledgment of receipt by fax on behalf of all parties with regard to Reasons for Judgment and Judgment. received on 14-JAN-2013

Reasons for Judgment and Judgment dated 14-JAN-2013 rendered by The Honourable Mr. Justice Barnes Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: dismissed Filed on 14-JAN-2013 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1180 page(s) 312 - 312

Ottawa 08-JAN-2013 BEFORE The Honourable Mr. Justice Barnes Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: F.Costin Duration per day: 08-JAN-2013 from 09:30 to 13:00 Courtroom : Courtroom No. 1, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Danielle Parent Total Duration: 3h30min Appearances: Anthony Creber and Livia Aumand 613-786-0140 representing Applicant Jonathan Stainsby 416-360-3568 representing Respondent Teva Canada Limited No one appearing xxx-xxx-xxxx representing Respondent Minister of Health Christopher VanBarr 613-786-8675 representing Respondent/Patentee Takeda Pharmaceutical Company Limited Comments: loose authorities were provided to the Court on behalf of the Respondent 68 C.P.R.(3d) 332 and 2011 FCA 57 Parties are permitted to file submissions on costs. Minutes of Hearing entered in Vol. 873 page(s) 275 - 282 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Livia Aumand confirming service of Supplemantal Book of Authorities upon all parties by personal service on 04-JAN-2013 filed on 04-JAN-2013

Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 04-JAN-2013

Solicitor's certificate of service on behalf of Andy Radhakant confirming service of doc. #46 & book of authorities upon Applicant Respondent by personal service on 21-NOV-2012 filed on 21-NOV-2012

Book of Authorities consisting of 1 volume(s) on behalf of Respondent received on 21-NOV-2012

Respondent's Record Number of copies received/prepared: 3 on behalf of Respondent filed on 21-NOV-2012

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 25-SEP-2012

Solicitor's certificate of service on behalf of Livia Aumand confirming service of Doc. 44 Book of Authorities upon All Respondents by personal service on 25-SEP-2012 filed on 25-SEP-2012

Applicant's Record Number of copies received/prepared: 3 on behalf of Applicant filed on 25-SEP-2012 Document placed in Annexes E F

Solicitor's certificate of service on behalf of Livia Aumand confirming service of the invalidity evidence of the Applicant upon Respondent and Respondent Patentee, Takeda Pharmaceutical Company Limited by personal service on 11-MAY-2012 filed on 11-MAY-2012

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 03-MAY-2012 directing that "The parties will utilize the hearing date of 8-JAN-2013 for the hearing of any issues remaining in this matter, including, if it is deemed by the parties more appropriate, the subject matter of the Notice of Motion submitted by the Applicant on 5-APR-2012. The parties shall follow for all matters, the schedule already set out in the Order of 10-FEB-2012." placed on file on 03-MAY-2012 Confirmed in writing to the party(ies)

Ottawa 03-MAY-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Directions issued at the conclusion held in chambers by way of Conference Call Duration per day: 03-MAY-2012 from 10:00 to 10:02 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 2min Appearances: Anthony Creber and Cristin Wagner (613) 786-0140 representing Applicant Jonathan Stainsby (416) 360-3568 representing Respondent Teva Canada Limited Christopher Van Barr (613) 786-8675 representing Respondent Patentee Takeda Pharmaceutical Company Limited * no one appearing * representing Respondent Minister of Health Minutes of Hearing entered in Vol. 861 page(s) 383 - 384 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Order of the Court dated 13-APR-2012 placed on file on 16-APR-2012

Order (time and place) dated 13-APR-2012 rendered by G. Calamo, Judicial Administrator and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 08-JAN-2013 to begin at 09:30 duration: 1d language: E Filed on 13-APR-2012 cc's sent to parties entered in J. & O. Book, volume 1154 page(s) 177 - 178 Transmittal letters placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 10-APR-2012 directing that "As per the parties' agreement, all but one of the hearing dates scheduled to begin 8-JAN-2013 may be released. The Judicial Administrator shall advise the parties of the date that has been retained." placed on file on 10-APR-2012 Confirmed in writing to the party(ies)

Ottawa 10-APR-2012 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: A further Case Management Conference will be held at 10:00 a.m. on 3-MAY-2012 held in chambers by way of Conference Call Duration per day: 10-APR-2012 from 10:00 to 10:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 30min Appearances: Anthony Creber and Cristin Wagner (613) 233-1781 representing Applicant Jonathan Stainsby and Andy Radhakant (416) 360-3568 representing Respondent Teva Canada Limited Christopher Van Barr (613) 786-8675 representing Respondent Patentee Takeda Pharmaceutical Company Limited * no one appearing * representing Respondent Minister of Health Comments: The Court issued Directions after the CMC concluded Minutes of Hearing entered in Vol. 860 page(s) 223 - 225 Abstract of Hearing placed on file

Letter from Applicant dated 05-APR-2012 enclosing a Notice of Motion and Affidavit in support (as well as a copy of Canadian Patent No. 1,340,794) If the relief sought in the Notice of Motion cannot be granted at the Case Management Conference scheduled to be held on 10-APR-2012; the Applicants request that the Motion be set down and a schedule be set for the exchange of Motion Records. *Letter and Notice of Motion placed on main file; Affidavit of Erin McIntomy sworn 5-APR-2012 and copy of '794 Patent placed in Annex "E" received on 05-APR-2012

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 02-APR-2012 directing that "A case management telephone conference will be held at 10:00 a.m. on 10-APR-2012." placed on file on 02-APR-2012 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 27-MAR-2012 re: Letter dated 26-MAR-2012

Letter from Applicant dated 26-MAR-2012 requesting a case management conference and providing the joint dates of availability of the Applicant, the Respondent Teva Canada Limited, and the Respondent Patentee Takeda Pharmaceutical Company Limited. The Minister of Health has advised that they will not participate. received on 27-MAR-2012

Letter sent by Registry on 16-MAR-2012 to all parties (e-mail message) re: advising that it is the Court's practice to only schedule case management conferences upon the provision of mutual dates of availability of all counsel (sample Direction attached). Should any party determine that a case management conference is necessary; the request should include dates of availability for the month of April, 2012. Copy placed on file.

Letter from Applicant dated 09-MAR-2012 further to the Respondent Teva's letter dated 8-MAR-2012; attaching a copy of a letter from the Applicant to Teva dated 9-MAR-2012 and requesting that the Court schedule a case management conference received on 09-MAR-2012

Copy of a Letter from Respondent Teva Canada Ltd. to Applicant dated 08-MAR-2012 in response to the Applicant's letter dated 5-MAR-2012 received on 08-MAR-2012

Copy of a Letter from Applicant to Respondent dated 05-MAR-2012 We have received your letter of today's date...we are confused by your letter and require additional information before we will be in a position to respond. It is unclear to us whether Teva has withdrawn its NOA pursuant to s.5(6) of the PMNOC Regulations. We would appreciate receiving evidence regarding the specific reason for the withdrawal, and in particular receiving answers to the following questions: (see letter for details) Without the evidence we believe it is premature to schedule a case management conference. received on 05-MAR-2012

Letter from Respondent dated 05-MAR-2012 in response to the letter sent to the Court on February 29 by counsel for Lilly. We wish to advise the Court that Teva has withdrawn the March 11, 2011 Notice of Allegation and detailed statement in respect to Canadian Patent No. 1,340,794...For greater certainty, Teva has not withdrawn the NOA in respect to Cdn. Patent No. 2,400,155 (the "155" patent)...we respectfully submit that this proceeding ought to be dismissed. We suggest that any case management issues resulting from these facts be addressed at a case management teleconference should the Court wish to convene one. If this is the case, we are available the week of March 5 (not a.m. of March 5) and the week of March 12. received on 05-MAR-2012

Letter from Applicant dated 29-FEB-2012 advising the Court of the status of this proceeding...By letter to the Court dated Feb.6, 2012, Teva requested, on consent, that the deadline for service of its evidence on validity be extended to Feb. 10, 2012. This request was granted by Order dated Feb. 10, 2012. Subsequently, Teva requested a further extension to Feb. 21, 2012. Lilly consented to Teva's request reluctantly... Despite these repeated extensions, Lilly was not served with Teva's evidence on invalidity on or after Feb. 21, 2012. As Lilly can rely upon the statutory presumtion of validity in the absence of evidence to the contrary, it appears that the hearing should now take no more that half an hour and there will be no need for Lilly to rely upon any evidence to establish the parties' validity...we do not anticipate any issue with proceeding on the scheduled start date of January 8, 2013. In light of Teva's failure to serve any evidence, we wish to adise the Court that Lilly intends to file its application record shortly without filing any evidence to support the validity of its patent. received on 29-FEB-2012

Acknowledgment of Receipt received from all parties via email on Feb. 10, 2012 with respect to doc. 41 placed on file on 10-FEB-2012

Order dated 10-FEB-2012 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from the Respondent(Teva) dated 06-FEB-2012 re: Parties request for revisions to the scheduling Order dated November 28,2011 Result: 1. Teva's evidence on invalidity shall be served no later than February 10, 2012. 2. The Applicants' evidence on invalidity will be served no later than May 11, 2012. 3. Cross-excaminations shall be completed by July 27, 2012. 4. Lilly's application record shall be due no later than 60 days following the completion of cross-examinations. 5. Teva's responding record shall be due on the earlier of 60 days after the filing of Lilly's record or 30 days before the scheduled hearing date, whichever is earliest. 6. The parties shall, no later than May 25, 2012, file written representations as to a schedule for the next steps to be taken in this proceeding. Filed on 10-FEB-2012 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1148 page(s) 385 - 386 Interlocutory Decision

Communication to the Court from the Registry dated 06-FEB-2012 re: Letter dated 6-FEB-2012

Letter from Respondent Teva Canada Limited dated 06-FEB-2012 requesting revisions to the Scheduling Order on consent received on 06-FEB-2012

Proof of receipt received from all parties with respect to Order Doc. 40 Transmitted by e-mail. placed on file on 29-NOV-2011

Order dated 28-NOV-2011 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent Teva Canada Limited dated 16-NOV-2011 Result: granted in part "1. The Respondent Teva's evidence on invalidity shall be served no later than 27-JAN-2012. 2. The Applicant's evidence on invalidity will be served no later than 27-APR-2012. 3. Cross-examinations shall be completed no later than 27-JUL-2012. 4. Lilly's Application Record shall be due no later than 60 days following the completion of cross-examinations. 5. Teva's responding record shall be due on the earlier of 60 days after the filing of Lilly's Record or 30 days before the scheduled hearing date, whichever is the earliest. 6. The parties shall, no later than 11-MAY-2012, file written representations as to a schedule for the next steps to be taken in this proceeding." Filed on 28-NOV-2011 copies sent to parties entered in J. & O. Book, volume 1142 page(s) 121 - 122 Interlocutory Decision

Communication to the Court from the Registry dated 17-NOV-2011 re: Letter dated 16-NOV-2011

Letter from Respondent Teva Canada Limited dated 16-NOV-2011 with the agreement of the Applicant, requesting revisions to the Scheduling Order received on 16-NOV-2011

Memorandum to file from Lise Lafrance dated 21-NOV-2011 The $50.00 filing fee for the Requisition for Hearing filed in this matter has been charged twice; once on Sept 30, 2011 and again on Oct 17, 2011. The reimbursement has been authorized by both sections 34 and 33. The Respondent's solicitor, Mr. J. Stainsby of Heenan Blaikie LLP and Ms. Alisha Schell, Law Clerk have been advised of the refund by phone and email. placed on file.

****** CANCELLED ****** Communication to the Court from the Registry dated 18-NOV-2011 re: Sent to Judy Charles - Director of General Proceeding for a financial approval as per section 34 and to Financial section as per section 33, regarding payment twice of the requisition for hearing.

Acknowledgment of Receipt received from all parties (by fax) with respect to doc #39 placed on file on 16-NOV-2011

Order (time and place) dated 16-NOV-2011 rendered by Acting Chief Justice S Noël and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 08-JAN-2013 to begin at 09:30 duration: 3d language: E Filed on 16-NOV-2011 cc's sent to parties entered in J. & O. Book, volume 1141 page(s) 133 - 134 Transmittal letters placed on file

Communication to the Court from the Registry dated 18-OCT-2011 re: Sent to JA's office for a hearing date to be set down.

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-OCT-2011 directing that TO THE REGISTRY: "the correspondence is to be placed before the Trial JA to be taken into consideration along with the Requisition for Hearing." placed on file on 14-OCT-2011

Letter from the Respondent Teva Canada Limited dated 13-OCT-2011 in response to the Applicant's reply correspondence dated 13-OCT-2011 (Scanned to the Court) received on 13-OCT-2011

Communication to the Court from the Registry dated 13-OCT-2011 re: Letters (3) dated 13-OCT-2011

Letter from Applicant dated 13-OCT-2011 in reply to the letter on behalf of the Respondent Teva Canada Limited dated 13-OCT-2011 received on 13-OCT-2011

Letter from Respondent Teva Canada Limited dated 13-OCT-2011 in response to the Applicant's letter dated 13-OCT-2011 received on 13-OCT-2011

Letter from Applicant dated 13-OCT-2011 further to the Requisition for Hearing filed 30-SEP-2011, advising of a change in their availability received on 13-OCT-2011

Proof of receipt received from all parties with respect to Order Doc. 38 placed on file on 12-OCT-2011

Order dated 11-OCT-2011 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 04-OCT-2011 Result: granted "1. The Respondent Teva's evidence on invalidity shall be served no later than 9-DEC-2011. 2. The Applicants' evidence on invalidity will be served no later than 16-MAR-2012. 3. Cross-examinations shall be completed no later than 8-JUN-2012. 4. Lilly's Application Record shall be due no later than 60 days following the completion of cross-examinations. 5. Teva's responding Record shall be due on the earlier of 60 days after the filing of Lilly's Record or 30 days before the scheduled hearing date. 6. The parties shall, no later than 5-APR-2012, file written representations as to a schedule for the next steps to be taken in this proceeding." Filed on 11-OCT-2011 copies sent to parties entered in J. & O. Book, volume 1136 page(s) 433 - 434 Interlocutory Decision

Communication to the Court from the Registry dated 05-OCT-2011 re: Letter dated 4-OCT-2011

Letter from Applicant dated 04-OCT-2011 with the agreement of the parties requesting modifications to the schedule. Draft order attached. received on 04-OCT-2011

Solicitor's certificate of service on behalf of Andy Radhakant confirming service of Doc.36 upon all parties by telecopier on 30-SEP-2011 filed on 30-SEP-2011

Requisition for hearing - Application from Respondent - Teva Canada Limited filed on 30-SEP-2011 Tariff Application or appeal - $50.00

Affidavit of service of Anna Di Domenico sworn on 15-SEP-2011 on behalf of respondent patentees confirming service of the evidence of Takeda Pharmaceutical company ltd. upon respondent Minister of Health by personal service on 15-SEP-2011 filed on 15-SEP-2011

Affidavit of service of Anna Di Domenico sworn on 15-SEP-2011 on behalf of respondent patentees confirming service of the evidence of Takeda Pharmaceutical company ltd. upon respondent Teva Canada Limited by personal service on 15-SEP-2011 filed on 15-SEP-2011

Affidavit of service of Marcail Delahunt sworn on 15-SEP-2011 on behalf of respondent-patentees confirming service of the evidence of Takeda Pharmaceutical company ltd. upon Applicant by personal service on 14-SEP-2011 filed on 15-SEP-2011

Acknowledgment of Receipt received from the Respondent (the Minister of Health) with respect to the Order of the Court dated August 24, 2011 placed on file on 07-SEP-2011

Acknowledgment of Receipt received from the Applicant, the Respondent (TEVA Canada) and the Intervenor (TAKEDA) with respect to the Order of the Court dated 24-AUG-2011 by EMAIL placed on file on 24-AUG-2011

Order dated 24-AUG-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: "1. The factual evidence of the Respondent Takeda and/or the Intervenors shall be served no later than September 15, 2011; 2. The Respondent Teva's evidence on invalidity shall be served no later than December 22, 2011; 3. The Applicants' evidence on invalidity will be served no later than March 30, 2012; 4. Cross-examinations shall be completed no later than March 30, 2012; 5. The parties shall, no later than April 15, 2012 file written representations as to a schedule for the nest steps to be taken in this proceeding; 6. The parties may serve and file a requistion for hearing at any time, and in any event, no later than September 30, 2011." Filed on 24-AUG-2011 copies sent to parties entered in J. & O. Book, volume 1132 page(s) 361 - 362 Interlocutory Decision

Ottawa 23-AUG-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: proposed schedule agreed to by parties held by way of Conference Call Duration per day: 23-AUG-2011 from 03:32 to 03:41 Courtroom : Judge's Chambers - Ottawa Court Registrar: Victoria Bell Total Duration: 11 mins Appearances: Ms. Cristin Wagner 613-786-8678 representing Applicant Ms. Livia Aumand 613-786-8678 representing Applicant Mr. Jonathan Stainsby 416-360-3568 representing Respondent Mr. Andy Radhakant 416-360-3568 representing Respondent Mr. Christopher Van Barr 613-786-8675 representing Respondent/Patentee Comments: the parties are to file their representations as to the schedule for the next steps to be taken in this proceeding by April 15, 2012; The requisition for hearing can be filed any time and in any event no later than September 30. Minutes of Hearing entered in Vol. 848 page(s) 126 - 128 Abstract of Hearing placed on file

Letter from Applicant dated 23-AUG-2011 with a proposed schedule regarding the remaining steps for this proceeding which counsel for the Applicant, the Respondent (Teva) and the Respondent/ Patentee (Takeda) have agreed upon. received on 23-AUG-2011

Acknowledgment of Receipt received from the Applicant, the Respondent and the Respondent/Patentee (TAKEDA) with respect to the Written Directions of the Court dated 23-AUG-2011 placed on file on 23-AUG-2011

Written directions received from the Court: Mireille Tabib, Prothonotary dated 23-AUG-2011 directing that "As the scheduling of the further steps in these proceedings may depend to a extent on the availability of information and documents from Japan, Counsel for Takeda's participation at the case management telephone conference this afternoon is required." placed on file on 23-AUG-2011 Confirmed in writing to the party(ies)

Letter from Respondent Minister of Health dated 28-JUL-2011 advising that carriage of this matter has been transferred to Eric Peterson and Teza Lwin at the Department of Justice Toronto received on 28-JUL-2011

Acknowledgment of Receipt received from all parties by fax June 27th with respect to Protective Order placed on file on 27-JUN-2011

PROTECTIVE ORDER dated 27-JUN-2011 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 22-JUN-2011 Result: See Order for details Filed on 27-JUN-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1127 page(s) 456 - 466 Interlocutory Decision

Communication to the Court from the Registry dated 23-JUN-2011 re: draft protective order received 22-JUN-2011

Letter from Respondent Teva Canada Limited dated 22-JUN-2011 Advising that the parties have reached an agreement with respect to a Protective Order. Draft Protective Order attached. received on 22-JUN-2011

Proof of receipt (facsimile confirmation) received from all parties with respect to Order Doc. 30 placed on file on 16-JUN-2011

Order dated 16-JUN-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: "UPON a case management telephone conference held on 15-JUN-2011 and continued from 13-JUN-2011. UPON counsel for Takeda advising that Takeda expected to only be in a position to present evidence from the inventor and/or Takeda by 15-SEP-2011, that is, later than initially anticipated in Lilly's motion to set a schedule. UPON the parties agreeing that the Applicant's evidence on infringement would be served by 22-AUG-2011, and that the scheduling of the balance of the steps to be taken in this application should be left to be determined at a case management telephone conference to take place at 3:30 p.m. on 23-AUG-2011, at which time Takeda should have a better idea of the exact timeframe for delivering its evidence and that timeframe for Teva to respond to Lilly's evidence on infringement could be better estimated, so as to arrive at the most efficient schedule. THIS COURT ORDERS that: 1. Teva shall disclose to the Applicant and to Takeda the information requested from Teva's ANDS and DMF by 20-JUN-2011. 2. The Applicant's evidence on infringement will be served no later than 22-AUG-2011. 3. A case management telephone conference will take place on 23-AUG-2011 beginning at 3:30 p.m. for the purpose of setting a schedule for the further steps to be taken in this proceeding." Filed on 16-JUN-2011 copies sent to parties entered in J. & O. Book, volume 1127 page(s) 209 - 210 Interlocutory Decision

Ottawa 15-JUN-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to issue held in chambers by way of Conference Call Duration per day: 15-JUN-2011 from 16:05 to 16:10 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 5min Appearances: John Norman and Isabel Raasch (613) 783-8848 representing Applicant and Respondent/Patentee Eli Lilly and Company Jonathan Stainsby and Andy Radhakant (416) 360-3568 representing Respondent Teva Canada Limited Christopher Van Barr (613) 786-8675 representing Respondent/Patentee Takeda Pharmaceutical Company Limited Minutes of Hearing entered in Vol. 845 page(s) 470 - 471 Abstract of Hearing placed on file

Ottawa 13-JUN-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: A further Case Management Conference will be held on 15-JUN-2011 at 4:00 p.m. held in chambers by way of Conference Call Duration per day: 13-JUN-2011 from 14:00 to 14:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 40 minutes Appearances: John Norman and Isabel Raasch (613) 783-8848 representing the Applicant and the Respondent/Patentee Eli Lilly and Company Jonathan Stainsby and Andy Radhakant (416) 360-3568 representing the Respondent Teva Canada Limited Christopher Van Barr (613) 786-8675 representing the Respondent/Patentee Takeda Pharmaceutical Company Limited * no one appearing * representing the Respondent Minister of Health Comments: Unless otherwise advised, a further CMC will also be held on 23-AUG-2011 at 3:30 p.m. Minutes of Hearing entered in Vol. 845 page(s) 353 - 355 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 01-JUN-2011 directing that "A further case management telephone conference will be held at 2:00 p.m. on 13-JUN-2011." placed on file on 01-JUN-2011 Confirmed in writing to the party(ies)

Ottawa 01-JUN-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: A further Case Management Conference will be held on 13-JUN-2011 at 2:00 p.m., unless the parties advise that the Applicant's Motion (Doc. 21) has been resolved held in chambers by way of Conference Call Duration per day: 01-JUN-2011 from 13:30 to 13:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 20min Appearances: John Norman and Isabel Raasch (613) 783-8848 representing the Applicant and the Respondent/Patentee Eli Lilly and Company Jonathan Stainsby and Andy Radhakant (416) 360-3568 representing the Respondent Teva Canada Limited Christopher Van Barr (613) 786-8675 representing the Respondent/Patentee Takeda Pharmaceutical Company Limited * no one appearing * representing the Respondent Minister of Health Minutes of Hearing entered in Vol. 845 page(s) 6 - 8 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 25-MAY-2011 directing that "A case management telephone conference will be held at 1:30 p.m. on 1-JUN-2011." placed on file on 25-MAY-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 24-MAY-2011 re: scheduling of CMC

Letter from Applicant dated 24-MAY-2011 in response to the Directions dated 18-MAY-2011, providing the parties' dates of availability for a CMC and advising that the Minister of Health will not participate. received on 24-MAY-2011

Proof of receipt (facsimile confirmation) received from all parties with respect to Directions dated 18-MAY-2011 placed on file on 18-MAY-2011

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-MAY-2011 directing that "Counsel for the Applicant is to provide all counsel's joint dates of availability to participate in a case management telephone conference to discuss its Motion (Doc. 21) and the scheduling thereof." placed on file on 18-MAY-2011 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 17-MAY-2011 re: Motion Doc. 21

Solicitor's certificate of service on behalf of John Norman confirming service of Book of Authorities upon Respondent by courier to Teva Canada and Min of Health,leaving copy to Takeda Pharmaceutic on 16-MAY-2011 filed on 17-MAY-2011

Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 17-MAY-2011

Solicitor's certificate of service on behalf of John Norman confirming service of Motion Record (Motion for Schedule and s.6(7)Production) upon Respondent by courier and by leaving a copy to one of the Respondents on 16-MAY-2011 filed on 16-MAY-2011

Motion Record containing the following original document(s): 21 22 23 24 25 26 Number of copies received: 3 on behalf of Applicant contained in Vols 1,2,3 filed on 16-MAY-2011 Document placed in Annexes C D

Written Submissions contained within a Motion Record on behalf of Applicant concerning the request of an Order implementing a schedule for this application filed on 16-MAY-2011

Affidavit of Arvie Anderson sworn on 12-MAY-2011 contained within a Motion Record on behalf of Applicant in opposition to Notice of Application Doc. No. 1 with Exhibits A filed on 16-MAY-2011

Affidavit of Dr. Michael Murray sworn on 16-MAY-2011 contained within a Motion Record on behalf of Applicant in opposition to Notice of Application Doc. No. 1 with Exhibits A filed on 16-MAY-2011

Affidavit of Loren David Grossman sworn on 12-MAY-2011 contained within a Motion Record on behalf of Applicant in opposition to Notice of Application Doc. No. 1 with Exhibits A to E filed on 16-MAY-2011

Affidavit of M. Delahunt sworn on 13-MAY-2011 contained within a Motion Record on behalf of Applicant in opposition to Notice of Application Doc. No. 1 with Exhibits A to H filed on 16-MAY-2011

Notice of Motion contained within a Motion Record on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order 1. Setting a schedule in this proceeding; 2. In the alternative, an order granting an extension of time to file its evidence by August 15, 2011; 3. Requiring the Respondent to produce specific documents and product samples within 15 days of the Order or to provide evidence of why it is not able to do so; 4. Requiring the Respondent, the Minister,to verify Teva's information; 5. An order granting Lilly its costs of this motion; 6. Such further and other order as to this Honourable Court may deem just. filed on 16-MAY-2011

Proof of Service of Fax received from All parties with respect to Doc. #20 (Order from CJL dated May 11, 2011). placed on file on 12-MAY-2011

Order dated 11-MAY-2011 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Status Review Result: Pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 11-MAY-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1123 page(s) 247 - 247 Interlocutory Decision

Solicitor's certificate of service on behalf of John Norman confirming service of doc. no. 18 upon Respondent, Teva Canada Limited by personal service on 05-MAY-2011 confirming service doc. no. 18 upon Respondent, the Minister of Health by courier on 05-MAY-2011 confirming service doc. no. 18 upon Respondent Patentee, Takeda Pharmaceutical Company Limited by personal service on 05-MAY-2011 confirming service doc. no. 18 upon Respondent Patentee, Eli Lilly and Company by personal service on 05-MAY-2011 filed on 05-MAY-2011

Amended Notice of Application filed on 05-MAY-2011

Order dated 04-MAY-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 6 Result: granted 1. This motion is granted and Lilly has leave to amend the Notice of Application in the form set out under Tab 6 of the April 26, 2011 motion record. 2. There is no order as to costs. Filed on 04-MAY-2011 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1122 page(s) 345 - 346 Interlocutory Decision

Draft Order concerning Motion Doc. No. 6 received on 03-MAY-2011

Communication to the Court from the Registry dated 03-MAY-2011 re: motion doc.6 on consent sent to Court for disposition.

Covering letter from Respondent Minister of Health dated 03-MAY-2011 concerning Doc. Nos. 15 16 placed on file on 27-APR-2011

Affidavit of service of Nicholas Young sworn on 27-APR-2011 on behalf of Respondent Minister of Health confirming service of Notice of Appearance doc.15 upon Applicant and Respondent Patentee Takeda by fax and Respondent and Respondent Patentee Eli Lilly by courier on 27-APR-2011 received by fax and filed on 27-APR-2011

Notice of appearance on behalf of Respondent Minister of Health filed on 27-APR-2011

Solicitor's certificate of service on behalf of ANDY RADHAKANT confirming service of DOC NO. 13 upon all parties by telecopier on 28-APR-2011 filed on 28-APR-2011

Notice of appearance on behalf of the respondent Teva Canada filed on 28-APR-2011

Affidavit of service of Susan Burkhardt sworn on 27-APR-2011 on behalf of Respondent, Takeda Pharmaceutical Company Limited confirming service of Notice of Appearance (Doc.27) upon Applicant by personal service on 27-APR-2011 confirming service Notice of Appearance (Doc.27) upon Respondents by telecopier on 27-APR-2011 filed on 27-APR-2011

Notice of appearance on behalf of Respondent Patentee, Takeda Pharmaceutical Company Limited filed on 27-APR-2011

Solicitor's certificate of service on behalf of Isabel Raasch confirming service of doc. 9 upon all parties by courier and personal service on 27-APR-2011 filed on 27-APR-2011

Motion Record containing the following original document(s): 6 7 8 Number of copies received: 3 on behalf of Applicant filed on 27-APR-2011

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 6 filed on 27-APR-2011

Affidavit of Erin McIntomny sworn on 26-APR-2011 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 6 with Exhibits A to E filed on 27-APR-2011

Notice of Motion contained within a Motion Record on behalf of Applicant in writing to be placed before the Court in Ottawa for leave to amend the Notice of Application filed on 27-APR-2011

Affidavit of service of Erin McIntomny sworn on 27-APR-2011 on behalf of Applicant confirming service of notice of application upon all parties by personal service on 21-APR-2011 filed on 27-APR-2011

Solicitor's certificate of service on behalf of Jay Zakaib confirming service of doc. 3 upon all parties by telecopier on 27-APR-2011 filed on 27-APR-2011

Notice of appearance on behalf of Eli Lilly and Company filed on 27-APR-2011

Service copy of Doc. No. 1 with proof of service upon Respondent on 21-APR-2011 filed on 21-APR-2011

Notice of application and 2 copies with regard to Section 6 of the Patent Medicines (NOC) Regulations filed on 21-APR-2011 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes